Risk of Thromboembolism in Patients with ALK and EGFR-Mutant Lung Cancer: A Cohort Study.

CONCLUSIONS: Patients with ALK-mutant advanced lung adenocarcinoma have the highest rate of TE. TE is associated with worse survival across molecular subtypes. These findings should be taken into consideration in decision-making regarding thromboprophylaxis.
PMID: 33314597 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - December 14, 2020 Category: Hematology Authors: Roopkumar J, Poudel SK, Gervaso L, Reddy CA, Velcheti V, Pennell NA, McCrae KR, Khorana AA Tags: J Thromb Haemost Source Type: research